Vancomycin-resistant enterococci isolated from animals and food

被引:96
作者
Robredo, B
Singh, KV
Baquero, F
Murray, BE
Torres, C
机构
[1] Univ La Rioja, Area Bioquim & Biol Mol, Logrono 26004, Spain
[2] Hosp Ramon y Cajal, Microbiol Serv, Madrid 28034, Spain
[3] Univ Texas, Sch Med, Ctr Study Emerging & Reemerging Pathogens, Houston, TX 77030 USA
[4] Univ Texas, Sch Med, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA
[5] Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA
关键词
Enterococcus; vancomycin-resistance; chicken; identification;
D O I
10.1016/S0168-1605(99)00195-6
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
One hundred and one chicken products, boiled ham and turkey cold meat were acquired fr om 18 different supermarkets in Spain during October 1997 to June 1998 and were analyzed for vancomycin-resistant enterococci (VRE). In the same way, 50 intestinal chicken samples from a slaughterhouse were also studied. VRE were detected in 25 of 92 samples of food of chicken origin (27.2%), but no VRE were found in cooked pork or turkey products. VRE were also detected in 8 of 50 intestinal chicken samples from the slaughterhouse (16%). VRE were identified as Enterococcus durans (n=11), Enterococcus faecalis (n = 10), Enterococcus faecium (n = 10) and Enterococcus hirae (n = 2), All these strains were characterized as belonging to the vanA genotype by polymerase chain reaction. Ampicillin. quinupristin/dalfopristin and high level aminoglycoside resistance were frequently found among these strains. Heterogeneity was observed in susceptibility patterns among VRE strains, even in those of the same species. The high rate of colonization of chicken products by vanA containing enterococci detected 6 months to 1 year after the banning of avoparcin as a growth promoter: supports other studies suggesting that the food chain could be a source of VRE colonization in humans and thus a source of VRE infections. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 42 条
[11]   CHARACTERIZATION OF THE CHROMOSOMAL AAC(6')-II GENE-SPECIFIC FOR ENTEROCOCCUS-FAECIUM [J].
COSTA, Y ;
GALIMAND, M ;
LECLERCQ, R ;
DUVAL, J ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1896-1903
[12]   Are glycopeptide-resistant enterococci in animals a threat to human beings? [J].
Das, I ;
Fraise, A ;
Wise, R .
LANCET, 1997, 349 (9057) :997-998
[13]  
DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46
[14]   Presence of vancomycin-resistant enterococci in farm and pet animals [J].
Devriese, LA ;
Ieven, M ;
Goossens, H ;
Vandamme, P ;
Pot, B ;
Hommez, J ;
Haesebrouck, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2285-2287
[15]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27
[16]   Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands [J].
Endtz, HP ;
vandenBraak, N ;
vanBelkum, A ;
Kluytmans, JAJW ;
Koeleman, JGM ;
Spanjaard, L ;
Voss, A ;
Weersink, AJL ;
VandenbrouckeGrauls, CMJE ;
Buiting, AGM ;
vanDuin, A ;
Verbrugh, HA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3026-3031
[17]   IDENTIFICATION OF ENTEROCOCCUS SPECIES ISOLATED FROM HUMAN INFECTIONS BY A CONVENTIONAL TEST SCHEME [J].
FACKLAM, RR ;
COLLINS, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) :731-734
[18]   Susceptibility to vancomycin of enterococci isolated from dairy products [J].
Giraffa, G ;
Sisto, F .
LETTERS IN APPLIED MICROBIOLOGY, 1997, 25 (05) :335-338
[19]   Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enteroeocci from humans, pigs, and poultry [J].
Jensen, LB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2463-2464
[20]   FECAL CARRIAGE AND NOSOCOMIAL SPREAD OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM [J].
JORDENS, JZ ;
BATES, J ;
GRIFFITHS, DT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (04) :515-528